The latest research on the sequelae of severe patients with new crown: One year after infection, 22% of patients still have upper respiratory tract symptoms

(Health Times reporter Zhao Yuanzhi) On May 17, the “BASIC Critical Care Medicine” official account released a research report on the mid- and long-term effects of new coronary pneumonia. -19 critically ill patients were monitored within 2 months and 12 months respectively, which also filled the gap in the current research on the survival of critically ill patients admitted to the ICU.

Data show that surviving COVID-19 patients after two months in the ICU weighed 9% less than their baseline body weight, and 13% were at the 2-month visit Still on oxygen therapy, in addition to 47% with restrictive syndrome, 10% with obstructive syndrome, 69% with reduced carbon monoxide diffusing capacity, and 56% with respiratory muscle weakness . Twenty-six percent of patients were unable to perform the 6-minute walk test due to muscle weakness.

Wait until 12 months, the surviving critically ill patients were 3% lower than their baseline body weight, and there were 16% of patients reported persistent pain or dysesthesia, 16% reported reduced range of motion in large joints of the body, 27% reported cosmetic changes in the skin of the neck, and 22% reported upper respiratory symptoms such as vocalizations changes, etc. An additional 65% of patients reported at least one symptom that was not present prior to ICU admission, and 61% of previously employed patients were able to return to work.

The results of the study showed that 12 months after recovery of COVID-19 patients admitted to the ICU, the vast majority of patients reported health-related quality of life, dyspnea and admission. Changes in symptoms that were not present before the ICU. And a large proportion of these patients did not end up returning to work.

For the long-term impact of new coronary pneumonia, recently, China-Japan Friendship Hospital Cao Bin team and Chinese Academy of Medical Sciences Institute of Pathogen Biology Wang Jianwei team in “The Lancet Respiratory Medicine” (The Lancet Respiratory Medicine) published a study of the 2-year follow-up results of hospitalized patients with new coronary pneumonia.

The results of the study show thatcompared to the general population, people who have recovered from COVID-19 tend to have poorer health 2 years after their initial infection, suggesting that some Patients need more time to fully recover. About half of those who have recovered from COVID-19 still have long-term effects of COVID-19, such as fatigue and difficulty sleeping, two years after they were discharged from the hospital. Moreover, the long-term impact of new coronary pneumonia on the quality of life, exercise capacity, and mental health of the population is relatively poor, and the use of medical care services is more frequent.